Access the original article via ACS Biochemistry here.
AI Summary
This article discusses the use of peptide-based strategies in combating Alzheimer's disease by targeting the aggregation of amyloid β proteins. The focus is on designing peptides that can disrupt the formation of amyloid fibrils associated with the disease. This approach aims to develop therapeutic interventions that can potentially halt or slow down the progression of Alzheimer's. The ergonomic design of peptides plays a crucial role in their ability to target and disrupt amyloid β aggregation. This research has significant implications for the development of novel treatments for Alzheimer's disease.
Access the original article via ACS Biochemistry here.